Intimation under Regulation 30 & 47 w.r.t Newspaper publication of Unaudited Financial Results for the quarter and half-year ended September 30, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kothari Fermentation & Biochem Ltd submitted a procedural intimation to BSE confirming that its unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2025 were published in Financial Express (English) and Jansatta (Hindi) on November 15, 2025. The board meeting approving these results was held on November 14, 2025. For Q2 FY26, standalone total income from operations stood at Rs. 2,396.11 lakhs versus Rs. 2,516.68 lakhs in Q2 FY25, while H1 FY26 revenue was Rs. 4,771.42 lakhs against Rs. 5,152.20 lakhs in H1 FY25. The company reported a net loss of Rs. 307.72 lakhs in Q2 FY26, widening from Rs. 175.00 lakhs loss in Q2 FY25, and an H1 FY26 net loss of Rs. 420.18 lakhs versus Rs. 65.23 lakhs loss a year ago. Basic and diluted EPS for Q2 FY26 was Rs. -2.05 and for H1 FY26 was Rs. -2.80, compared with Rs. -1.17 and Rs. -0.43 respectively in the prior-year periods.
While the filing is procedural, the underlying results show a notable deepening of losses and a revenue decline compared with the same period last year, which is likely to be viewed negatively by shareholders and could pressure the stock in the near term.